Alimentary Pharmacology & Therapeutics

Review article: complementary and alternative therapies for inflammatory bowel disease
pp. 341-349(9)
Authors: LANGMEAD, L.; RAMPTON, D. S.

Review article: non-biological liver support in liver failure
pp. 351-363(13)
Authors: LALEMAN, W.; WILMER, A.; EVENEPOEL, P.; VERSLYPE, C.; FEVERY, J.; NEVENS, F.

Influence of citalopram, a selective serotonin reuptake inhibitor, on oesophageal hypersensitivity: a double-blind, placebo-controlled study
pp. 365-370(6)
Authors: BROEKAERT, D.; FISCHLER, B.; SIFRIM, D.; JANSSENS, J.; TACK, J.

Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa
pp. 371-376(6)
Authors: WILLICH, S. N.; NOCON, M.; KULIG, M.; JASPERSEN, D.; LABENZ, J.; MEYER-SABELLEK, W.; STOLTE, M.; LIND, T.; MALFERTHEINER, P.

Long-term prognosis in Crohn's disease: factors that affect quality of life
pp. 377-385(9)
Authors: CANAVAN, C.; ABRAMS, K. R.; HAWTHORNE, B.; DROSSMAN, D.; MAYBERRY, J. F.

Pharmacokinetics and pharmacodynamic action of budesonide in children with Crohn's disease
pp. 387-396(10)
Authors: DILGER, K.; ALBERER, M.; BUSCH, A.; ENNINGER, A.; BEHRENS, R.; KOLETZKO, S.; STERN, M.; BECKMANN, C.; GLEITER, C. H.

Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practice
pp. 397-408(12)
Authors: LEE, S. S.; BAIN, V. G.; PELTEKIAN, K.; KRAJDEN, M.; YOSHIDA, E. M.; DESCHENES, M.; HEATHCOTE, J.; BAILEY, R. J.; SIMONYI, S.; SHERMAN, M.

Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B
pp. 409-419(11)
Authors: BUTI, M.; CASADO, M. A.; CALLEJA, J. L.; SALMERÓN, J.; AGUILAR, J.; RUEDA, M.; ESTEBAN, R.

Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection
pp. 421-427(7)
Authors: WONG, W. M.; GU, Q.; CHU, K.-M.; YEE, Y. K.; FUNG, F. M. Y.; TONG, T. S. M.; CHAN, A. O. O.; LAI, K. C.; CHAN, C. K.; WONG, B. C. Y.

Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction
pp. 429-435(7)
Authors: DE FRANCESCO, V.; MARGIOTTA, M.; ZULLO, A.; HASSAN, C.; VALLE, N. D.; BURATTINI, O.; CEA, U.; STOPPINO, G.; AMORUSO, A.; STELLA, F.; MORINI, S.; PANELLA, C.; IERARDI, E.

Three-year oral pantoprazole administration is effective for patients with Zollinger–Ellison syndrome and other hypersecretory conditions
pp. 437-444(8)
Authors: METZ, D. C.; COMER, G. M.; SOFFER, E.; FORSMARK, C. E.; CRYER, B.; CHEY, W.; PISEGNA, J. R.

Thalidomide: an effective anabolic agent in gastrointestinal cancer cachexia
pp. 445-446(2)
Authors: Wilkes, E. A.; Freeman, J. G.

Thalidomide: an effective anabolic agent in gastrointestinal cancer cachexia: authors' reply
pp. 446-447(2)
Authors: Ockenga, J.; Valentini, L.

Errata
pp. 449-449(1)